Workflow
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
TVGNTevogen Bio(TVGN) Globenewswire·2025-06-09 13:00

R&D and cross-functional operations will be centralized in a single location to enhance collaboration and operational efficiency.Tevogen.AI, strengthened by its partnership with Microsoft, continues to expand. An update on AI and other Company assets, previously estimated to have a market value of 10billion,isforthcoming.ShareholderswillsoonreceiveanupdateonTevogen’sgoaloffinalizingin−housemanufacturingcapabilities,whichareexpectedtosupportprojectedcumulativerevenuesof10 billion, is forthcoming.Shareholders will soon receive an update on Tevogen’s goal of finalizing in-house manufacturing capabilities, which are expected to support projected cumulative revenues of 10–14 billi ...